Brendan Adkinson
Yale University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Brendan Adkinson.
Biological Psychiatry | 2017
Jennifer H. Foss-Feig; Brendan Adkinson; Jie Lisa Ji; Genevieve Yang; Vinod H. Srihari; James C. McPartland; John H. Krystal; John D. Murray; Alan Anticevic
Recent theoretical accounts have proposed excitation and inhibition (E/I) imbalance as a possible mechanistic, network-level hypothesis underlying neural and behavioral dysfunction across neurodevelopmental disorders, particularly autism spectrum disorder (ASD) and schizophrenia (SCZ). These two disorders share some overlap in their clinical presentation as well as convergence in their underlying genes and neurobiology. However, there are also clear points of dissociation in terms of phenotypes and putatively affected neural circuitry. We highlight emerging work from the clinical neuroscience literature examining neural correlates of E/I imbalance across children and adults with ASD and adults with both chronic and early-course SCZ. We discuss findings from diverse neuroimaging studies across distinct modalities, conducted with electroencephalography, magnetoencephalography, proton magnetic resonance spectroscopy, and functional magnetic resonance imaging, including effects observed both during task and at rest. Throughout this review, we discuss points of convergence and divergence in the ASD and SCZ literature, with a focus on disruptions in neural E/I balance. We also consider these findings in relation to predictions generated by theoretical neuroscience, particularly computational models predicting E/I imbalance across disorders. Finally, we discuss how human noninvasive neuroimaging can benefit from pharmacological challenge studies to reveal mechanisms in ASD and SCZ. Collectively, we attempt to shed light on shared and divergent neuroimaging effects across disorders with the goal of informing future research examining the mechanisms underlying the E/I imbalance hypothesis across neurodevelopmental disorders. We posit that such translational efforts are vital to facilitate development of neurobiologically informed treatment strategies across neuropsychiatric conditions.
eLife | 2018
Katrin H. Preller; Joshua B. Burt; Jie Lisa Ji; Charles Schleifer; Brendan Adkinson; Philipp Stämpfli; Erich Seifritz; Grega Repovs; John H. Krystal; John D. Murray; Franz X. Vollenweider; Alan Anticevic
Background: Lysergic acid diethylamide (LSD) has agonist activity at various serotonin (5-HT) and dopamine receptors. Despite the therapeutic and scientific interest in LSD, specific receptor contributions to its neurobiological effects remain unknown. Methods: We therefore conducted a double-blind, randomized, counterbalanced, cross-over studyduring which 24 healthy human participants received either (i) placebo+placebo, (ii) placebo+LSD (100 µg po), or (iii) Ketanserin, a selective 5-HT2A receptor antagonist,+LSD. We quantified resting-state functional connectivity via a data-driven global brain connectivity method and compared it to cortical gene expression maps. Results: LSD reduced associative, but concurrently increased sensory-somatomotor brain-wide and thalamic connectivity. Ketanserin fully blocked the subjective and neural LSD effects. Whole-brain spatial patterns of LSD effects matched 5-HT2A receptor cortical gene expression in humans. Conclusions: Together, these results strongly implicate the 5-HT2A receptor in LSD’s neuropharmacology. This study therefore pinpoints the critical role of 5-HT2A in LSD’s mechanism, which informs its neurobiology and guides rational development of psychedelic-based therapeutics. Funding: Funded by the Swiss National Science Foundation, the Swiss Neuromatrix Foundation, the Usona Institute, the NIH, the NIAA, the NARSAD Independent Investigator Grant, the Yale CTSA grant, and the Slovenian Research Agency. Clinical trial number: NCT02451072.
bioRxiv | 2018
Murat Demirtas; Joshua B. Burt; Markus Helmer; Jie Lisa Ji; Brendan Adkinson; Matthew F. Glasser; David C. Van Essen; Stamatios N. Sotiropoulos; Alan Anticevic; John D. Murray
The large-scale organization of dynamical neural activity across cortex emerges through long-range interactions among local circuits. We hypothesized that large-scale dynamics are also shaped by heterogeneity of intrinsic local properties across cortical areas. One key axis along which microcircuit properties are specialized relates to hierarchical levels of cortical organization. We developed a large-scale dynamical circuit model of human cortex that incorporates heterogeneity of local synaptic strengths, following a hierarchical axis inferred from MRI-derived T1w/T2w mapping, and fit the model using multimodal neuroimaging data. We found that incorporating hierarchical heterogeneity substantially improves the model fit to fMRI-measured resting-state functional connectivity and captures sensory-association organization of multiple fMRI features. The model predicts hierarchically organized high-frequency spectral power, which we tested with resting-state magnetoencephalography. These findings suggest circuit-level mechanisms linking spatiotemporal levels of analysis and highlight the importance of local properties and their hierarchical specialization on the large-scale organization of human cortical dynamics.
Biological Psychiatry | 2018
Murat Demirtas; Joshua B. Burt; Markus Helmer; Jie Lisa Ji; Katrin H. Preller; Charlie Schleifer; Brendan Adkinson; Cameron Dowiak; Morgan Flynn; Alan Anticevic; John D. Murray
Biological Psychiatry | 2018
Brendan Adkinson; Charles Schleifer; Morgan Flynn; Antonija Kolobaric; Cameron Dowiak; Jie Lisa Ji; Nicole Santamauro; Vinod H. Srihari; Aleksandar Savic; Youngsun T. Cho; Stamatios N. Sotiropoulos; Alan Anticevic
Biological Psychiatry | 2018
Alan Anticevic; Charles Schleifer; Brendan Adkinson; Youngsun T. Cho; Peter T. Morgan; Aleksandar Savic; Murat Demirtas; Jie Lisa Ji; John D. Murray
Biological Psychiatry | 2018
Jie Lisa Ji; Brendan Adkinson; Murat Demirtas; Joshua B. Burt; Wanida Rattanasumawong; Stamatios N. Sotiropoulos; John D. Murray; Alan Anticevic
Biological Psychiatry | 2018
Brendan Adkinson; Yicheng Long; Charles Schleifer; Morgan Flynn; Antonija Kolobaric; Cameron Dowiak; Jie Lisa Ji; Nicole Santamauro; Youngsun T. Cho; Stamatios N. Sotiropoulos; Alan Anticevic
Biological Psychiatry | 2018
Youngsun T. Cho; Charlie Schleifer; Flora Moujaes; Martina Starc; Jie Lisa Ji; Nicole Santamauro; Brendan Adkinson; Michael Lituchy; John H. Krystal; John D. Murray; Grega Repovs; Alan Anticevic
Biological Psychiatry | 2018
Brendan Adkinson; Antonija Kolobaric; Morgan Flynn; Cameron Dowiak; Charles Schleifer; Nicole Santamauro; Caroline Beech; Justin Lobe; Olivia Zalevsky; Youngsun T. Cho; Christopher Pittenger; Alan Anticevic